21 April 2012

21 April: Economy News  : Kotak Securities PDF link

Please Share:: Bookmark and Share India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��


Economy News
 Despite weak demand in traditional export markets such as the US and
the European Union, India’s export shipments crossed the $300-billion
official target set for the fiscal.
 India has allowed aviation companies to borrow up to $1 billion from
overseas to meet their working capital requirement for one year (ET).
Corporate News
 The government has approved Cairn India's proposal to ramp up output
from its Rajasthan block by another 25,000 barrels per day after its
partner in the block,state-owned  ONGC, endorsed the view that
increasing production would not damage the reservoir and the
infrastructure is adequate to handle about 16% jump in crude oil output
(ET).
 Kingfisher Airlines  has secured permission from the Directorate
General of Foreign Trade (DGFT) to import aviation turbine fuel (ATF)
directly. The UB group airline, which is struggling to raise funds and has
curtailed its operations to 100-120 flights each day, was the first to
demand direct import of ATF last November (BS).
 Hindalco Industries plans to raise $580 million in 10-year bonds at
9.55%. Standard Chartered Bank and HDFC Bank are likely the arrangers
to the deal (ET).
 Techno Electric has envisaged Rs 10 bn investment to raise power
generation capacity over six fold in the next five years. The company
plans to increase our generation capacity to 1,250 Mw by the end of the
12th Five Year Plan period entirely through non-conventional sources (BS)
 The Comptroller & Auditor General of India (CAG) has said the
Maharashtra government's City and Industrial Development Corporation
(Cidco) extended undue benefits of about Rs 4.6 bn to Larsen & Toubro
(L&T)  on incomplete projects on the development of an integrated
complex at the Seawood railway station in Navi Mumbai (BS).
 Mahindra Satyam  will invest $240 million globally to set up
infrastructure and support services for its clients over the next three
years (ET).
 Ranbaxy Laboratories and its parent Daiichi Sankyo has said that they
will launch Sevikar,a hypertension drug in Romania under their
collaborative business strategy. Terapia Ranbaxy, a subsidiary of Ranbaxy
in Romania will launch the drug there (ET).

No comments:

Post a Comment